N/A
N=24
Sevoflurane Concentrations in Children
Anesthetic · Sevoflurane · Age
Bottom Line
View on ClinicalTrials.gov: NCT06510803 ↗Enrolled (actual)
24
Serious AEs
0.0%
Results posted
Feb 2026
Primary outcome: Primary: Ratios of the Inspired to Expired Sevoflurane Concentrations During Induction of Anesthesia — 0; 0; 0.684; 0.6615 ratio
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- The washin of sevoflurane in the GE Ohmeda workstation (Drug)
- Age
- Pediatric · 2+ yrs
- Sex
- All
- Sponsor
- State University of New York at Buffalo
- Primary completion
- Oct 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Ratios of the Inspired to Expired Sevoflurane Concentrations During Induction of Anesthesia |
0; 0; 0.684; 0.6615; 0.816; 0.80 | — |
| SECONDARY Maximum Inspired Concentration at 1 Minute of Induction |
7.8; 6.4 | — |
| SECONDARY Maximum Sevoflurane Concentrations During Induction of Anesthesia |
8.5; 7.2 | — |
| SECONDARY Time to Reach 90% of the Maximum Inspired Concentration |
0.5; 1.75 | — |
Summary
The sevoflurane concentrations (as well as vital signs, child's date of birth, type of surgery) will be recorded during the first 10 minutes of anesthesia.
Eligibility Criteria
Inclusion Criteria
- scheduled for elective surgery under general anesthesia,
- American Society of Anesthesiologists physical status 1 or 2 fasted, unpremeditated
Exclusion Criteria
- parents refuse consent
- presence of moderate or severe cardiorespiratory disease
- difficult airway
- malignant hyperthermia
- neuromuscular disorders
- obesity
- obstructive sleep apnea
Data sourced from ClinicalTrials.gov (NCT06510803). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.